Published: August 15, 2017

Introduction {#sec1}
============

Lysine acetylation on proteins has been shown to broadly regulate diverse sets of cellular functions ([@bib10]). Understanding the dynamics of protein acetylation in regulating cellular pathways is therefore key to deciphering its biological functions ([@bib66]). However, comprehensive analysis of lysine acetylation is technologically achievable only recently, using antibodies recognizing acetylated lysine residues ([@bib31]). To date, only a few studies have described further acetylome maps in mammals. Early studies identified hundreds of acetylated peptides in the liver, with a strong enrichment in mitochondrial proteins ([@bib31], [@bib62], [@bib82]). More recently, multi-organ studies identified thousands of acetylated peptides in rodents, opening new avenues regarding the regulation of acetylation and its effect on cellular functions, including metabolism ([@bib38], [@bib78]). Descriptions of mechanisms involved in regulating such acetylation, mainly through enzymatically controlled deacetylation, are rising and strongly linked to metabolism and physiological conditions ([@bib44]). However, the dynamics of protein acetylation are still poorly described, despite the currently known regulation by food-related metabolites and nutrient availability.

Through the regulation of diurnal feeding rhythms and nutrient metabolism, the circadian clock is likely an important modulator of protein acetylation. The circadian clock, an endogenous and autonomous oscillator with a nearly 24-hr period, coordinates most aspects of physiology and behavior in mammals ([@bib21]). This oscillatory clockwork is organized in a hierarchical manner, with a master clock in the suprachiasmatic nuclei of the hypothalamus that communicates timing cues to downstream oscillators in peripheral tissues. At the molecular level, rhythms in gene expression are generated by interconnected transcriptional and translational feedback loops in which multiple layers of control, including temporal, transcriptional, post-transcriptional, and post-translational regulation, play important roles ([@bib13]). Although efforts have been conducted in the last decade to comprehensively study transcriptional regulation orchestrated by the circadian clock, regulation at the proteome level is still largely unexplored territory, despite recent advances in the field ([@bib42], [@bib48], [@bib59], [@bib73]). Evidence also indicates that the circadian clock is a key regulator of deacetylase activity, affecting mitochondrial function ([@bib52]). However, little is known about the global diurnal acetylome, despite the recent description of 19 diurnally acetylated sites in wild-type (WT) mouse liver ([@bib40]). Using optimized sample preparation, including antibody-based enrichment protocols combined with sensitive nano-reverse-phase liquid chromatography (RP-LC) tandem MS (MS/MS) applied to total (TE) and nuclear (NE) mouse liver protein extracts harvested during two diurnal cycles, we were able to detect 1,831 and quantified 1,050 acetylated sites, of which around 13% presented a diurnal acetylation pattern. These acetylated proteins are characterized by a bimodal distribution of peak times. Proteins acetylated during the night are enriched in cytoplasmic and nuclear proteins, whereas proteins acetylated during the day are enriched in mitochondrial proteins. This rhythm in mitochondria is associated with the activity of the nicotinamide adenine dinucleotide (NAD)^+^-dependent SIRT3 deacetylase. Rhythmic acetylated proteins are involved in several key metabolic pathways, and metabolite levels within these pathways correlated with acetylation levels. Of interest is that the diurnal distribution of acetylation and metabolites is highly disturbed in clock-disrupted animals such as *Bmal1* knockout (KO) and *Cry1*/*2* double knockout (DKO) mice, mainly through the differential regulation of NAD^+^ synthesis, supporting a crucial role of the circadian and feeding rhythms in finely tuning the diurnal liver acetylome.

Results {#sec2}
=======

The Acetylome of the Mouse Liver {#sec2.1}
--------------------------------

To obtain further insights into the diurnal acetylation in mouse liver, we performed an in vivo stable isotope labeling by amino acids (SILAC) MS-based proteomic experiment in which TE and NE protein extracts were collected every 3 hr during two consecutive days under light-dark conditions and night-restricted feeding. After trypsin digestion, these extracts were enriched for acetylated peptides ([Experimental Procedures](#sec4){ref-type="sec"}). Relative acetylated peptide abundance in the resulting 16 TE and 16 NE samples was quantified using a common SILAC total or nuclear reference extract, respectively ([Figure S1](#mmc1){ref-type="supplementary-material"}A), whose labeling efficiency has already been reported ([@bib42]). This experimental setup allowed the identification of 1,298 lysine acetylation sites in TE and 533 in NE, of which 236 unique sites were commonly detected in both datasets ([Figure S1](#mmc1){ref-type="supplementary-material"}B; [Table S1](#mmc2){ref-type="supplementary-material"}). The reproducibility of our experiment was high because the correlation between biological replicates was 76% on average ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Moreover, as a proxy of nuclear enrichment quality, 75% of the obtained raw MS signal in NE originated from acetylated peptides of nuclear proteins ([Figure S1](#mmc1){ref-type="supplementary-material"}D). For further analysis, only acetylation sites yielding relative quantitative measurements in at least 8 of the 16 samples were considered. Additionally, only sites with a previously quantified accumulation of the corresponding protein in TE ([@bib42]) and NE ([@bib73]) were retained ([Figure 1](#fig1){ref-type="fig"}A; [Table S2](#mmc3){ref-type="supplementary-material"}). Using such criteria, 797 acetylation sites within 309 proteins in TE and 253 acetylation sites within 162 proteins in NE were quantified ([Figure 1](#fig1){ref-type="fig"}B; [Table S2](#mmc3){ref-type="supplementary-material"}). In TE, the majority of identified and quantified acetylation sites originated from cytoplasmic and mitochondrial proteins, whereas the NE dataset was enriched in acetylation sites from nuclear proteins and proteins shuttling between the cytoplasmic and nuclear compartments ([Figure 1](#fig1){ref-type="fig"}C; [Figure S1](#mmc1){ref-type="supplementary-material"}D). In total, 44 proteins were found acetylated in both datasets, likely proteins shuttling between different organelles or dually targeted proteins that can be present in different compartments, as reported for mitochondrial/nuclear proteins ([Figure 1](#fig1){ref-type="fig"}C; [@bib45]). Comparison of our datasets ([Table S2](#mmc3){ref-type="supplementary-material"}) with the previously published diurnal acetylome performed on whole liver extracts under ad libitum feeding ([@bib40]) showed that, besides our increased coverage, which is more than doubled, our quantified TE acetylome includes 70% of the aforementioned data ([Figure 1](#fig1){ref-type="fig"}D). Additional comparisons of this dataset with published mitochondrial liver acetylomes ([@bib24], [@bib56], [@bib62], [@bib67]) showed that 70% of our acetylated proteins were present in at least two of these datasets, corroborating the enrichments for mitochondrial proteins in our liver acetylome ([Figure 1](#fig1){ref-type="fig"}E). The remaining non-overlapping proteins are likely cytoplasmic or nuclear proteins that are not present in theses mitochondrial datasets.Figure 1Characterization of the Liver Acetylome(A) Distribution of sample number for the quantified acetylation sites in TE (red bars plotted on the left y axis) and NE (green bars plotted on the right y axis).(B) Venn diagram showing the number of acetylated proteins quantified in TE (red circle, 309 acetylated proteins identified) and NE (green circle, 162 acetylated proteins identified).(C) Distribution of cellular localization of proteins with quantified acetylation sites in TE (left), TE and NE (center), and NE (right). Data are expressed in percent.(D) Venn diagram comparing the TE dataset of acetylated proteins with the previous circadian liver acetylome ([@bib40]) (176 unique acetylated proteins identified).(E) Matrix layout for all intersections (vertical bars), sorted by size, of our TE dataset, with the data from studies performed using liver mitochondrial protein extract: [@bib62] (356 acetylated proteins), [@bib57] (483 acetylated proteins), [@bib67] (729 acetylated proteins), and [@bib24] (834 acetylated proteins). Color-coded circles in the matrix indicate sets that are part of the intersection and, the top horizontal bar graph displays the protein number for each study.

The Rhythmic Acetylome of the Mouse Liver {#sec2.2}
-----------------------------------------

We next identified actively acetylated lysine by analyzing the rhythmicity of the acetylation signal normalized by its corresponding protein signal ([@bib43]; [Experimental Procedures](#sec4){ref-type="sec"}; [Table S2](#mmc3){ref-type="supplementary-material"}). Using this relative acetylation signal, we first observed that most of the rhythmic acetylated peptides are found on non-rhythmic proteins, which characterize an active acetylation process. Hence, we found 133 rhythmic acetylated lysines (p \< 0.05), 106 in TE and 27 in NE and 3 of them found in both datasets ([Figure S2](#mmc1){ref-type="supplementary-material"}A; [Table S2](#mmc3){ref-type="supplementary-material"}). These rhythmic sites were found in 73 unique proteins in TE (including 8 rhythmic at the protein level; [@bib42]), 23 in TE (including 13 rhythmic at the protein level in the nucleus; [@bib73]), and 2 proteins common between TE and NE. The proportion of about 13% of rhythmic acetylated sites is higher compared with the previously published liver diurnal acetylome (19 rhythmic acetylation sites in the WT, about 6% of the dataset; [@bib40]), probably because of the higher coverage and time resolution as well as the feeding schedule in the present study. Comparing the intersection between the two datasets revealed a minor overlap; only 5 acetylation sites were found in common in both studies ([Figure S2](#mmc1){ref-type="supplementary-material"}A). We additionally identified acetylation sites with a 12-hr period: 34 sites within 30 proteins in TE and 17 sites within 14 proteins in NE ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C; [Table S2](#mmc3){ref-type="supplementary-material"}).

Using protein localization databases, we annotated the cellular localization of all the rhythmic acetylated sites. Surprisingly, clear localization-specific phases were observed. Although mitochondrial proteins were acetylated during the day, when nutrient and energy are depleted, cytoplasmic and nuclear proteins were preferentially acetylated during the night, when nutrients are available at high levels ([Figures 2](#fig2){ref-type="fig"}A and 2B). Compared with other post-translational modifications, such as rhythmic phosphorylation ([@bib60], [@bib73]), despite a few high amplitudes of acetylation sites observed in the nucleus and mitochondria, we found that the amplitudes of rhythmic acetylation were relatively low. This could reflect the fact that acetylation/deacetylation are low-stoichiometry reactions ([@bib74]) compared with phosphorylation ([@bib77]). Moreover, only a small fraction of the pool of proteins is subjected to acetylation on lysine, leading to the observed global low change on acetylation levels ([Figure 2](#fig2){ref-type="fig"}C). Validation of rhythmic acetylation of mitochondrial superoxide dismutase 2 (SOD2) at lysine 68 ([@bib9]) was performed by western blot and presented similar diurnal variation as found by MS ([Figure 2](#fig2){ref-type="fig"}D).Figure 2Rhythmicity Analysis of the Liver Acetylome(A--C) Heatmaps showing rhythmic acetylation sites normalized by their corresponding total protein amount in TE (A) and NE (B) under light/dark and night-restricted feeding conditions. Data were standardized by rows, and gray blocks indicate missing protein data. The polar plots on the right of each heatmap display peak phase distribution of the rhythmic acetylation (Ac) sites, and (C) shows amplitude. The colors of the polar plots (A and B) and histograms (C) indicate Ac sites that have a corresponding total protein with a defined mitochondrial (n = 80 Ac sites, red) or cytoplasmic (n = 40 Ac sites, blue) localization or Ac sites that are identified in NE (n = 27 Ac sites, green).(D) Western blot (WB) analysis of total protein extracts using acetyl-K68 SOD2 (top blot) or total SOD2 (bottom blot). MS data in red, mean ± SEM, are from [Table S2](#mmc3){ref-type="supplementary-material"}. WB data in black, mean ± SEM, are from three independent biological samples and represent the ratio of the acetyl-K68 SOD2 signal on the total SOD2 signal. Data (MS and WB) are normalized to the temporal mean. Naphtol blue black staining of the membranes was used as a loading control (LC) and served as a reference for normalization of the quantified values.

Acetylation is acknowledged in general as a passive process mainly regulated by the availability of acetyl-coenzyme A (CoA) and counteracted by the regulated orchestration of deacetylation ([@bib11]). In mammalian cells, acetyl-CoA concentration is not homogeneous. Indeed, its synthesis and accumulation are cell compartment-specific ([@bib65]) and regulated by feeding/fasting cycles ([@bib63]). For instance, during the fasting period, a 10-fold higher concentration of acetyl-CoA was observed in the mitochondria, where it is synthetized from acetate by acetyl-CoA synthetase 2 (ACECS2, encoded mainly by the *Acss3* gene in the mouse liver) ([@bib72]). In contrast, lower concentrations were found in the cytoplasm and the nuclear compartments, where acetyl-CoA is produced from mitochondrially derived citrate by ATP citrate lyase (ACLY) or from acetate by acetyl-CoA synthetase 1 (ACECS1, encoded by the *Acss2* gene in the mouse) during feeding time ([@bib75]). Remarkably, the observed compartment-specific rhythmic acetylation is well correlated with this food-driven acetyl-CoA synthesis in the respective compartment.

Although ACSS3 is not rhythmically expressed in TE or liver mitochondria ([@bib48]), ACSS2 and ACLY ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E), with the latter being highly expressed compared with other ACSS isoforms ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G), presented a synchronized diurnal accumulation in the mouse liver in both TE and NE. The maximum of expression of these acetyl-CoA-producing enzymes occurred during the light period in TE and at the night-day transition in NE, when cytoplasmic and nuclear acetylation levels were low ([Figures 2](#fig2){ref-type="fig"}A and 2B; [Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E). Proteomic data from circadian clock-disrupted mice in TE showed a minor disturbance of ACLY and ACSS2 expression ([Figure S2](#mmc1){ref-type="supplementary-material"}H). Although ACSS3 expression was increased in *Bmal1* KO mice, it was previously shown that acetyl-CoA concentration is not affected in this model ([@bib52]).

Together, these data are in line with the fact that lysine acetylation is mainly driven by passive acetylation caused by food-driven fluctuation of acetyl-CoA availability in their respective cell compartments; i.e., day in mitochondria and night in the cytoplasmic and nuclear compartments ([@bib63]). The expression levels of acetyl-CoA-producing enzymes as well as the circadian clock components appear to weakly affect this diurnal compartment-specific regulation of acetyl-CoA level in a normal feeding regimen, as already shown ([@bib8], [@bib52]). However, the mitochondrial acetylation peak phase is likely followed by sirtuin-dependent deacetylation events in the opposite phase. Sirtuin-dependent deacetylation has been shown to be clock-regulated ([@bib52]) and could be involved in the observed rhythmic acetylation.

The Rhythmic Acetylome Is Modulated by Circadian Clock-Orchestrated Rhythmic Deacetylation {#sec2.3}
------------------------------------------------------------------------------------------

Previously published results suggest that rhythmic deacetylation by sirtuins is likely involved in establishment of the rhythmic acetylome ([@bib52]). Among sirtuins, SIRT2 is present mainly in the cytosol, whereas SIRT6 and SIRT7 are located in the nucleus. SIRT1 shuttles between the cytosol and the nucleus and is therefore involved in deacetylation within these two organelles ([@bib44]). Although SIRT4 ([@bib41]) and SIRT5 ([@bib16]) have very little deacetylase activity, SIRT3 is likely the main mitochondrial deacetylase. Of interest is that SIRT3-deacetylated proteins have been extensively studied in different mouse tissues and, notably, in the liver ([@bib14], [@bib24], [@bib36], [@bib57], [@bib74]). Many characterized targets of SIRT3 presented a rhythmic acetylation in our dataset, with a clear phase preference during the day, synchronized with rhythmically acetylated proteins in the mitochondria ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Table S3](#mmc4){ref-type="supplementary-material"}). In contrast, non-SIRT3 targets displayed a bimodal maximum of acetylation during the middle of the day and night, mostly synchronized with cytoplasmic and nuclear proteins. This observation was confirmed by the fact that most rhythmic SIRT3 targets are mitochondrial proteins, whereas the majority of rhythmic non-SIRT3 targets are localized in the cytoplasm, where they can be deacetylated by another unidentified deacetylase ([Figure 3](#fig3){ref-type="fig"}C). The 12-hr acetylation sites we identified were not enriched in SIRT3 targets compared with 24-hr acetylation rhythms ([Figure S3](#mmc1){ref-type="supplementary-material"}A), suggesting that SIRT3 is not implicated in implementing 12-hr rhythms of acetylation. Remarkably, as described previously ([@bib1], [@bib73]), SIRT1 and its activator RPS19BP1 ([@bib32]), as well as SIRT2 and SIRT7, are rhythmic and synchronized in the nuclear compartment, with a maximum of accumulation during the night-day transition, after the peak of acetylation in this organelle ([Figures S3](#mmc1){ref-type="supplementary-material"}B--S3D), and could therefore also be involved in this deacetylation process.Figure 3Rhythmic Behavior of Non-SIRT3 and SIRT3 Targets(A--C) Peak phase (A), amplitude (B), and cellular localization (C) of rhythmic acetylation sites non-targeted (left) or targeted (right) by the SIRT3 deacetylase. Acetylation sites were defined as targeted by SIRT3 when their levels were significantly upregulated in *Sirt3* KO mice in [@bib57], [@bib24], or [@bib14] ([Table S3](#mmc4){ref-type="supplementary-material"}).

NAD^+^ Synthesis and the Diurnal Acetylome Are Regulated by the Circadian Clock and the Feeding Schedule {#sec2.4}
--------------------------------------------------------------------------------------------------------

As recently shown, the diurnal activity of SIRT3 is regulated by the circadian clock-regulated NAD^+^ salvage pathway through the transcriptional control of nicotinamide phosphoribosyltransferase (*Nampt*), whose expression level peaks at the day-night transition ([@bib47], [@bib52], [@bib55]). However, the level of NAD^+^ appeared to be only partially related to *Nampt* expression, with the feeding regimen playing an important role in rhythmic NAD^+^ accumulation. Under fasting conditions, liver rhythmic NAD^+^ levels are maximal during the day ([@bib52]), whereas they are biphasic under ad libitum feeding ([@bib55]). The strong influence of feeding schedule on NAD^+^ accumulation was additionally confirmed by mathematical modeling ([@bib76]). Hence, in addition to clock disruption, the feeding schedule also appears to be a key player that fine-tunes NAD^+^ diurnal oscillations. Hepatic NAD^+^ production originates mainly from the amidated route ([@bib46]), which includes the aforementioned NAD^+^ salvage pathway involving NAMPT but also the nicotinamide riboside (NR) pathway. This NR pathway synthesizes NAD^+^ from the dietary supplies of NR and nicotinamide mononucleotide (NMN) and involves nicotinamide riboside kinase 1 (NRK1), encoded by the *Nmrk1* gene ([@bib58]). In addition, the existence of organelle-specific NAD^+^ biosynthesis enzymes also suggests that the regulation of NAD^+^ pools is organelle-specific. Indeed, in the cytosol and the nucleus, NAD^+^ is likely the product of NMN conversion by NMNAT1 and 2, whereas synthesis of the mitochondrial pool involves NMNAT3 ([@bib5]). This suggests that the availability of NAD^+^ precursors during the feeding period may affect the rhythmic deacetylation through rhythmic activation of sirtuins, and not only the circadian clock via the regulation of NAMPT expression.

To test this hypothesis, we first investigated the effect of the circadian clock on rhythmic global acetylation by studying lysine acetylation in liver extracts from *Cry1*/*2* and *Bmal1* KO mice that present an inactivated circadian clock ([@bib68], [@bib71]). As shown in [Figure 4](#fig4){ref-type="fig"}A, global acetylation was slightly decreased in *Cry1*/*2* DKO mice but increased in *Bmal1* KO mice. This change in global acetylation could therefore reflect the regulation of NAD^+^ synthesis by the circadian clock and its associated regulation of sirtuin activity. Accordingly, we observed higher and lower NAD^+^ levels in the livers of *Cry1*/*2* DKO and *Bmal1* KO mice, respectively, showing that the clock indeed controlled NAD^+^ synthesis ([Figure 4](#fig4){ref-type="fig"}B). As mentioned before, although the circadian clock regulation of NAD^+^ synthesis through the NAD^+^ salvage pathway seems to be active under fasting conditions ([@bib52]) or for cell-autonomous synthesis of NAD^+^ ([@bib47]), feeding-related pathways likely affect NAD^+^ synthesis. We therefore speculated about the regulation of NAD^+^ synthesis by the clock through the nutrient-dependent NR pathway. The genes encoding NAMPT and NRK1 as well as NMNAT3 presented a rhythmic expression at the mRNA level ([Figure 4](#fig4){ref-type="fig"}C). Although *Nampt* expression was, as described, perturbed in clock-disrupted mice ([Figure 4](#fig4){ref-type="fig"}C), this was also the case for *Nmrk1* at both the mRNA and protein levels ([Figures 4](#fig4){ref-type="fig"}C and 4D). However, *Nmnat3* expression as well as that of the non-rhythmic *Nmnat1* were not significantly affected in clock-disrupted mice ([Figure 4](#fig4){ref-type="fig"}C), whereas *Nmnat2* is not expressed in mouse liver.Figure 4Regulation of Global Acetylation and NAD^+^ Metabolism by the Circadian Clock(A) Western blot analysis of global lysine acetylation performed on total protein extract from *Cry1/2* DKO, *Bmal1* KO, and their corresponding WT control mice (left). Naphtol blue black staining of the membrane was used as a loading control (center) and served as a reference for normalization of the quantified values displayed at the right. The average acetylation level was compared between clock-disrupted mice and their controls using Student's t test (n = 12/genotype). Error bars represent min to max.(B) NAD^+^ liver concentrations in *Bmal1* KO (n = 2/time point) and *Cry1/2* DKO mice (n = 2/time point) and their corresponding WT controls (mean ± SEM).(C) Top: mRNA expression levels of *Nampt*, *Nmrk1*, *Nmnat1*, and *Nmnat3* in *Bmal1* KO mice (green) and their WT littermates (black) under night-restricted feeding conditions. Bottom: the same results in *Cry1*/*2* DKO (red) mice and their WT controls (black). The data are from [@bib2]; n = 2 for each time point and each genotype). Error bars represent ±SEM.(D) WB analysis in TE extracts of NRK1 in *Bmal1* KO and *Cry1/2* DKO mice. Quantifications of the blots are displayed below. Naphtol blue black staining of the membranes was used as a loading control and served as a reference for normalization of the quantified values. Error bars represent ±SEM.(E) Temporal binding of circadian clock core regulators on the *Nampt*, *Nmrk1*, and *Nmnat3* gene promoters. At each time point, for each factor, the averages of all rhythmic bindings are presented. The data are from [@bib34].

To test whether the circadian clock directly regulates these genes, we took advantage of the recently published report regarding rhythmic genome-wide binding of circadian clock regulators ([@bib34]) to study their binding on these specific genes. Interestingly, similar to the rhythmic binding of BMAL1 and NPAS2 around CT8 and the PER and CRY proteins at CT16 on the *Nampt* promoter, the promoter of *Nmrk1* was bound by BMAL1, CLOCK around CT6, and PER2 around CT16. Although BMAL1, CRY1, and CRY2 also bound the promoter of *Nmnat3* around CT0 and PER2 bound at CT16, they have apparently minor effect on its expression ([Figure 4](#fig4){ref-type="fig"}E), which is likely regulated by additional transcription factors regulated by food-derived signals, potentially contributing to its dysregulation observed in obesity ([@bib15], [@bib30]). Taken together, these results highlighted the fact that not only the NAD^+^ salvage pathway but also the feeding-related NR pathway are influenced by the circadian clock and that both play an important role in clock-regulated NAD^+^ synthesis.

Pathways Affected by Circadian Clock-Regulated Acetylation and Links with Metabolism {#sec2.5}
------------------------------------------------------------------------------------

A search for metabolic pathways enriched in rhythmically acetylated proteins revealed a significant involvement in amino acid and lipid metabolism in addition to citrate (tricarboxylic acid cycle \[TCA\]) and urea cycles. Moreover, many proteins involved in mitochondrial oxidative phosphorylation, ketogenesis, and ethanol metabolism were also rhythmically acetylated ([Figure 5](#fig5){ref-type="fig"}; [Figure S4](#mmc1){ref-type="supplementary-material"}; [Table S4](#mmc5){ref-type="supplementary-material"}). Interestingly, many proteins in these pathways showed deregulated acetylation levels in *Cry1*/*2* and *Bmal1* KO mice ([Figure S5](#mmc1){ref-type="supplementary-material"}). More specifically, we found that many proteins involved in these pathways presented an increased acetylation level in both KO mice, mainly at ZT18, when rhythmically acetylated mitochondrial proteins showed a minimum level of acetylation in WT mice. Interestingly, acetylation controls several proteins of the TCA cycle. Succinate dehydrogenase A (SDHA) ([@bib12], [@bib18]), malate dehydrogenase 2 (MDH2) ([@bib33]), pyruvate dehydrogenase alpha 1 (PDHA) ([@bib17]), and isocitrate dehydrogenase 2 (IDH2) ([@bib81]) are all characterized by reversible acetylation regulated through deacetylation by the deacetylase SIRT3. Except for MDH2, this acetylation leads to enzyme activity inhibition. The global increased acetylation of TCA cycle enzymes in *Cry1*/*2* and *Bmal1* KO mice ([Figure S5](#mmc1){ref-type="supplementary-material"}) could be a factor explaining the decreased TCA cycle activity that occurs in *Bmal1* KO mice ([@bib52]).Figure 5Metabolic Pathways Affected by Rhythmic AcetylationRhythmic protein acetylations and their regulation by the circadian clock for fatty acid oxydation, urea cycle, ketogenesis, and ethanol metabolism. Each dot represents a unique acetylation site within the protein of interest. Grey and black dots represent non-rhythmic identified and quantified acetylation sites, respectively, whereas phases of maximum acetylation levels for rhythmic acetylation sites are color-coded. Superscripted red dots and green asterisks indicate protein acetylation levels significantly different in *Cry1/2* DKO and *Bmal1* KO mice, respectively.

Similar observations were made for the urea cycle, where carbamoyl phosphate synthetase (CPS1) ([@bib50]), glutamate oxaloacetate transaminase 2 (GOT2) ([@bib79]), and ornithine carbamoyltransferase (OTC) ([@bib23], [@bib80]) also possess reversible acetylation as an enzymatic activity regulator. These enzymes also displayed increased acetylation levels in *Cry1*/*2* and at ZT18 in *Bmal1* KO mice. Most of the enzymes involved in ketogenesis are prone to be regulated by SIRT3 ([@bib14]), notably 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) ([@bib64]), showing circadian clock-regulated acetylation. The acetyl-CoA synthetase enzymes in the ethanol metabolism pathway are also regulated by SIRT3-dependent deacetylation, which activates their enzymatic activity ([@bib22], [@bib61]). In the same pathway, numerous aldehyde dehydrogenases are known to be deacetylated in a sirtuin-dependent fashion ([@bib37], [@bib83]) and show circadian clock-regulated acetylation. Regarding fatty acid oxidation, the enzymes acyl-CoA synthetase I (ACSL1) ([@bib19]), long-chain acyl CoA dehydrogenase (ACADL) ([@bib26]), and enoyl-CoA hydratase/3-hydroxyacyl-CoA (EHHADH) ([@bib82]) have also been shown to be regulated by acetylation and present altered acetylation in clock-deficient mice. Mitochondrial oxidative phosphorylation protein complexes I to V have been shown to be acetylated ([@bib31]); this acetylation is at least partly under the control of SIRT3 ([@bib54]). As previously shown for several of these ([@bib7]), rhythmic acetylation of these proteins was found to be subjected to circadian clock regulation. Altogether, these observations suggest that clock-controlled diurnal acetylation could have an effect on global liver metabolism via the regulation of enzymatic activity.

To identify potential effects of the described circadian clock-regulated rhythmic acetylation on metabolism, in addition to the proteomic approach we also performed proton nuclear magnetic resonance (^1^H-NMR) spectroscopy-based metabolomics on hydrophilic liver tissue extracts from WT and *Bmal1* KO mice. As described in [Figures 6](#fig6){ref-type="fig"} and [S6](#mmc1){ref-type="supplementary-material"}, several reciprocities between levels of metabolites and differential acetylation levels in *Bmal1* KO mice could be found. For instance, in the urea cycle, low levels of arginine and ornithine during the day in *Bmal1* KO animals paralleled the decreased acetylation of ASS1 and ARG1 during this period and the increased acetylation of OTC at ZT18. Although the function of ASS1 and ARG1 acetylation has not yet been described, we could speculate that a decrease in OTC activity because higher acetylation at ZT18 also contributes to this process. In the same pathway, matched low levels of glutamate, α-ketoglutarate, pyruvate, and alanine were also observed during the day, preceded by increased acetylation and inhibition of GLUD1, CPS1, and GOT2 at the end of the night. Several of these metabolites are also part of the imbricate TCA cycle and tie up with the decreased succinate level at day-night transition, when many enzymes presented an increased acetylation level ([Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}). In addition to these pathways, we also observed a strong correspondence between low levels of lysine at night-day transition and acetylation of aminoadipate-semialdehyde synthase (AASS), suggesting an uncharacterized link between the acetylation and activity of this enzyme. Finally, several aldehyde dehydrogenases of the ethanol pathway displayed disturbed acetylation in KO mouse liver that could be put alongside a general decrease in acetate levels. We also noted in many cases that quantitative profiles of metabolites are correlated with the profile of NAD^+^ level in *Bmal1* KO mice, suggesting a potential role of NAD^+^-dependent deacetylase in the regulation of enzyme activities in the aforementioned metabolic pathways or at least a strong correlation between the two processes ([Figures 4](#fig4){ref-type="fig"}B and [6](#fig6){ref-type="fig"}).Figure 6Impact of Rhythmic Acetylation on Metabolite LevelsLiver temporal profiles of metabolites in *Bmal1* KO (green lines) and WT littermates (black lines). Data (mean ± SEM) are expressed relative to the temporal mean of WT values. The analysis is related to key metabolites of the urea cycle, ketogenesis, and ethanol metabolism. Student's t test was performed to compare the average level of metabolite at every time point between different genotypes (n = 4). ^∗^p \< 0.05 between *Bmal1* KO and WT mice.

Discussion {#sec3}
==========

Although phosphorylation has been considered the major modifier of protein activity and function for a long time, many additional modifications, including acetylation, have emerged as important post-translational modifications ([@bib25]). The high-coverage acetylome described here allowed us to gain more insights about diurnal protein acetylation in mouse liver compared with previous work ([@bib40]). In particular, we showed that acetylation of mitochondrial proteins is in the opposite phase compared with the extra-mitochondrial compartments, probably because of the different sirtuins locally expressed within these cell compartments. These rhythmic sirtuin activities, and particularly SIRT3 in mitochondria, are likely the consequence of rhythmic accumulation of NAD^+^ in the different cell compartments ([@bib52]). Although regulation of the NAD^+^ salvage pathway by the circadian clock through the regulation of *Nampt* expression appeared to be critical during fasting or for cell-autonomous NAD^+^ synthesis ([@bib47], [@bib55]), this pathway seems to be less critical under normal conditions, where NAD^+^ seems to originate mostly from food metabolism. Indeed, the circadian clock controls NAMPT, involved in the synthesis of NAD^+^ through the salvage pathway or from the food-contained nicotinamide (NAM), but also NRK1, involved in the synthesis of NAD^+^ from NR and NMN ([@bib58]; [Figure 7](#fig7){ref-type="fig"}A). The circadian clock therefore regulates most aspects of NAD^+^ synthesis in the mouse liver and, by this, enlarges the landscape of interconnection between the circadian clock and sirtuins ([@bib39]).Figure 7Interconnection between Feeding and Circadian Rhythms in Regulating NAD^+^ Synthesis and Circadian Clock Disruption Effects on Lysine Succinylation and Malonylation(A) Rhythmic feeding effect (blue) versus the circadian clock (red) on key components implicated in acetyl-CoA-dependent acetylation and the regulation NAD^+^ synthesis during the day (fasting phase) and night (feeding phase).(B and C) Western blot analysis of global lysine succinylation (B) and malonylation (C) performed on total protein extract from *Cry1/2* DKO, *Bmal1* KO, and their corresponding WT control mice (left). Naphtol blue black staining of the membrane was used as a loading control (center) and served as a reference for normalization of the quantified values displayed at the right. Average acetylation levels were compared between clock-disrupted mice and their controls using Student's t test (n = 4). Error bars represent min to max.

In contrast to the observed maximum acetylation of mitochondrial proteins during the night under fasting conditions because of the more active SIRT3 activity during this period ([@bib52]), we observed, under our night feeding conditions, maximal acetylation of these proteins during the day, mostly as a consequence of the food-dependent increase in acetyl-CoA synthesis ([@bib63]). Under these two conditions, this maximal acetylation is correlated with the minimal mitochondrial activity ([@bib48], [@bib52]), deacetylation of mitochondrial proteins being key to maintaining proper mitochondrial activity ([@bib26]). In addition, feeding rhythms also appear to be important in this pathway because restricted night feeding is able to restore normal rhythmic mitochondrial activity in *Per2* KO animals ([@bib48]), highlighting the strong interconnection between feeding and the circadian clock in regulating mitochondrial activity. In addition, supplementation strategies designed to improve NAD^+^ concentration protect against metabolic diseases, neurodegenerative disorders, and age-related physiological decline in mammals ([@bib6]). The key role of the circadian clock in regulating NAD^+^ synthesis suggests that timing of supplementation should also be taken into account as an important aspect of this strategy.

Our study also shows the key role of the circadian clock in the metabolism of vitamin B3, nicotinic acid (NA) constituting another source of NAD^+^. Interestingly, circulating levels of several vitamins, like vitamins A, B9, B12, D, E, and K, showed a diurnal rhythm in mammals ([@bib28], [@bib53]), but the role of the circadian clock in these rhythms has not yet been established. One exception is vitamin B6, for which a clear role of the clock has been demonstrated through the regulation of pyridoxal kinase (*Pdxk*) by the circadian clock-regulated proline acidic amino acid-rich basic leucine zipper (PARbZip) transcription factors ([@bib20]). All of these elements suggest that the circadian clock, in addition to its role in macronutrient metabolism, also plays a crucial role in micronutrient and vitamin metabolism. Given the broad effect of these circadian clock-regulated vitamins in general metabolism, in particular neurotransmitter synthesis for vitamin B6 ([@bib20]) and mitochondrial activity for vitamin B3 ([@bib44]), this pathway likely contributes to the metabolic deficiency observed in circadian clock-deficient animals.

Although acetylation is currently the most described modification of lysine residues by acylation, lysine can also alternatively be formylated, methylated, propionylated, butyrylated, crotonylated, malonylated, succinylated, glutarylated, or myristoylated ([@bib11]). Sirtuins are also involved in the deacylation of these lysine modifications, playing an important role in the regulation of metabolism. SIRT5, for instance, has recently been shown to regulate glycolysis through reversible malonylation ([@bib49]), the urea cycle through deglutarylation ([@bib69]), and ketogenesis as well as other metabolic pathways through desuccinylation ([@bib51], [@bib56]). Interestingly, these activities are also NAD^+^-dependent and, as a result, potentially subjected to circadian clock regulation. Using antibodies specific to malonylated and succinylated lysine, we also showed that malonylation was increased in the liver of *Bmal1* KO mice, whereas succinylation was decreased in *Cry1*/*2* DKO mice and increased in *Bmal1* KO mice ([Figures 7](#fig7){ref-type="fig"}B and 7C), in accordance with NAD^+^ levels in these animals. These additional findings suggest that the circadian clock, in addition to its key role in the regulation of transcription, is also able to regulate key metabolic function through post-translational regulation events, including acetylation, and probably other metabolism-related lysine acylations.

Experimental Procedures {#sec4}
=======================

Animal Experiments {#sec4.1}
------------------

Animal studies were conducted in accordance with the regulations of the veterinary office of the Canton of Vaud. *Cry1*/*2* DKO mice in the C57BL/6J genetic background ([@bib4]) and *Bmal1* KO mice ([@bib29]) have been described previously. Mice had free access to food and water in 12-hr light/12-hr dark cycles under standard animal housing conditions. However, unless indicated otherwise, in all experiments animals were fed only at night, starting 4 days before the experiment. SILAC mice, generated according to a standard procedure ([@bib35]), have been described previously ([@bib42]).

Total and Nuclear Protein Extraction {#sec4.2}
------------------------------------

TE and NE protein extracts were generated as described previously ([@bib73]). The detailed procedure can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Analysis of Acetylation by RP-LC MS/MS {#sec4.3}
--------------------------------------

The detailed procedure for the RP-LC MS/MS analysis of lysine-acetylated enriched peptides can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. The accession numbers for the mass spectrometry proteomic data reported in this paper were deposited in the ProteomeXchange Consortium via the PRIDE partner repository: [PXD005317](pride:PXD005317){#intref0010} and [PXD005310](pride:PXD005310){#intref0015} for TE and NE, respectively.

Annotation of Protein Localization {#sec4.4}
----------------------------------

We used UNIPROT ([@bib70]) and COMPARTMENT ([@bib3]) to annotate protein localization (i.e., nuclear, shuttling, cytoplasmic, or mitochondrial), for TE and NE.

Analysis of Rhythmicity {#sec4.5}
-----------------------

We assessed the rhythmicity in temporal accumulations of acetylated sites normalized by corresponding protein levels using harmonic regression as described previously ([@bib42]).

KEGG Pathway Enrichment Analysis {#sec4.6}
--------------------------------

The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment for quantified proteins was performed using the Database of Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources 6.8. at <https://david.ncifcrf.gov/home.jsp> ([@bib27]).

Western Blotting {#sec4.7}
----------------

20 μg of total liver protein was used for western blotting according to standard procedures. Densitometry analyses of the blots were performed using the ImageJ software. Naphtol blue black staining of the membranes was used as a loading control and served as a reference for normalization of the quantified values. References for antibodies used in this paper can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

NAD^+^ Concentration {#sec4.8}
--------------------

Liver NAD^+^ concentration was assessed with the EnzyChrom NAD/NADH Assay Kit (BioAssay Systems) on ∼25 mg of liver tissue and according to the manufacturer's instructions.

^1^H NMR Spectroscopic Analysis of Liver Metabonome {#sec4.9}
---------------------------------------------------

The detailed procedure for ^1^H NMR metabonomic analysis of liver extracts can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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